T. Rowe Price Associates’s Tectonic Therapeutic, Inc. Common Stock TECX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $365K | Buy |
18,322
+5,515
| +43% | +$110K | ﹤0.01% | 2449 |
|
2025
Q1 | $227K | Buy |
+12,807
| New | +$227K | ﹤0.01% | 2580 |
|
2021
Q1 | – | Sell |
-2,876
| Closed | -$481K | – | 2871 |
|
2020
Q4 | $481K | Sell |
2,876
-72,124
| -96% | -$12.1M | ﹤0.01% | 2257 |
|
2020
Q3 | $11.7M | Sell |
75,000
-7,663
| -9% | -$1.2M | ﹤0.01% | 1262 |
|
2020
Q2 | $17.3M | Buy |
82,663
+8,118
| +11% | +$1.7M | ﹤0.01% | 1180 |
|
2020
Q1 | $13.9M | Sell |
74,545
-5,250
| -7% | -$980K | ﹤0.01% | 1167 |
|
2019
Q4 | $19.3M | Sell |
79,795
-15,244
| -16% | -$3.68M | ﹤0.01% | 1193 |
|
2019
Q3 | $16.1M | Buy |
95,039
+27,686
| +41% | +$4.69M | ﹤0.01% | 1213 |
|
2019
Q2 | $13.1M | Buy |
67,353
+16,957
| +34% | +$3.31M | ﹤0.01% | 1269 |
|
2019
Q1 | $13.3M | Sell |
50,396
-16,759
| -25% | -$4.43M | ﹤0.01% | 1273 |
|
2018
Q4 | $13.4M | Buy |
67,155
+320
| +0.5% | +$63.9K | ﹤0.01% | 1255 |
|
2018
Q3 | $41.6M | Buy |
66,835
+33,502
| +101% | +$20.9M | 0.01% | 984 |
|
2018
Q2 | $11.4M | Buy |
+33,333
| New | +$11.4M | ﹤0.01% | 1325 |
|